Alpha-1 Antitrypsin Deficiency Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft ‑Versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant
Condition: Graft Versus Host Disease Interventions: Biological: Alpha-1 antitrypsin (AAT); Biological: Placebo Sponsor: CSL Behring Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Effects of Different Exercise Training Modalities in Alpha-1 Antitrypsin Deficiency Patients
Conditions: Chronic Obstructive Pulmonary Disease; Alpha 1-Antitrypsin Deficiency Intervention: Procedure: Exercise training Sponsor: Klinikum Berchtesgadener Land der Schön-Kliniken Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 14, 2019 Category: Research Source Type: clinical trials
